隴神戎發(300534.SZ)半年度淨利預計為25萬元-32萬元 同比扭虧為盈
格隆匯7月14日丨隴神戎發(300534.SZ)披露半年度業績預吿,預計2021年半年度歸屬於上市公司股東的淨利潤25萬元-32萬元,同比扭虧為盈。
業績變動原因:
1、報吿期內,公司強化營銷隊伍建設和業務整合,積極開拓市場,精耕細作,藥品銷售收入同比增長24%左右;上年同期公司全面落實甘肅省委省政府“六保”政策精神和《甘肅省政府國資委關於落實減免中小微企業房租政策的通知》要求,支持園區租賃小微企業復工復產,減免四家租賃單位疫情期間三個月房屋租金,本報吿期內無租金減免事項,房屋租賃收入增長;政府補助較上年同期增加影響其他收益增長;報吿期內收到王青川支付蘭州三元藥業有限責任公司2020年度業績承諾補償款項442.51萬元,影響營業外收入增長;上述因素綜合影響歸屬於上市公司股東的淨利潤增長。
2、報吿期內,非經常性損益對淨利潤的影響金額預計為585元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.